Japan Intellectual Property Rights: LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR TREATMENT OF PSMA-EXPRESSING CANCERS

Japan, Sept. 18 -- UNIV HEIDELBERG,DEUTSCHES KREBSFORSCHUNGSZENTRUM has got intellectual property rights for 'LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR TREATMENT OF PSMA-EXPRESSING CANCERS.' Other related details are as follows:

Application Number: JP,2024-061255

Category (FI): A61K51/04,100,A61K47/54,A61K51/04,200,A61P35/04,C07D487/08,C07F7/24,A61P35/00,A61P15/00,A61P13/08,C07D257/02

Stage: PROBLEM TO BE SOLVED: To provide improved ligands that interact with PSMA and carry appropriate radionuclides to provide advantageous options for the detection, treatment and management of PSMA-expressing cancers, in particular prostate cancer.SOLUTION: The present inven...